Immunovant Inc.

NASDAQ: IMVT · Real-Time Price · USD
15.48
-0.18 (-1.15%)
At close: Jun 16, 2025, 3:59 PM
15.49
0.06%
Pre-market: Jun 17, 2025, 04:33 AM EDT

Immunovant Revenue

Immunovant reported an annual revenue of $0, reflecting a 0% growth. For the quarter ending March 31, 2025, Immunovant generated $160K in revenue.
Revenue (ttm)
$0
Revenue Growth
0%
Price / Sales Ratio
0
Revenue / Employee
$0
Employees
362
Market Cap
2.65B

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.